Overview

The Effect of Vaginal Estrogen Cream on Subjective and Objective Symptoms of Urodynamic Stress Incontinence

Status:
Withdrawn
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double blinded placebo controlled trial over a period of 3 months. Study subjects will be randomized into 2 groups: Those receiving drug (1gm of estrogen vaginal cream [EVC] at bed time 3 times a week), and those receiving placebo.
Phase:
N/A
Details
Lead Sponsor:
University of California, Irvine
Treatments:
Estrogens